Human Fatty Liver Disease: Old Questions and New Insights

被引：1688

作者：

Cohen, Jonathan C. ^{[1
]}

Horton, Jay D. ^{[1
,2
]}

Hobbs, Helen H. ^{[1
,2
,3
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA

[2] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA

[3] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA

来源：

SCIENCE | 2011年 / 332卷 / 6037期

关键词：

INSULIN-RESISTANCE; HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; ADIPOSE-TISSUE; PREVALENCE; GLUCOSE; TRANSPLANTATION; CHOLESTEROL; LIPOGENESIS; POPULATION;

D O I：

10.1126/science.1204265

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.

引用

页码：1519 / 1523

页数：5

共 51 条

[1] Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32
[2] Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, Curtis K.
Caldwell, Stephen H.
[J]. CLINICS IN LIVER DISEASE, 2009, 13 (04) : 511 - +
[3] Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, Curtis K.
Northup, Patrick G.
Al-Osaimi, Abdullah M. S.
Caldwell, Stephen H.
[J]. JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 371 - 379
[4] Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to Hyperlipidemia in glycogen storage disease type 1
Bandsma, Robert H. J.
Prinsen, Berthil H.
Van Der Velden, Monique De Sain
Rake, Jan-Peter
Boer, Theo
Smit, G. Peter A.
Reijngoud, Dirk-Jan
Kuipers, Folkert
[J]. PEDIATRIC RESEARCH, 2008, 63 (06) : 702 - 707
[5] Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
Basantani, Mahesh K.
Sitnick, Mitch T.
Cai, Lingzhi
Brenner, Daniel S.
Gardner, Noah P.
Li, John Zhong
Schoiswohl, Gabriele
Yang, Kui
Kumari, Manju
Gross, Richard W.
Zechner, Rudolf
Kershaw, Erin E.
[J]. JOURNAL OF LIPID RESEARCH, 2011, 52 (02) : 318 - 329
[6] Prevalence of hepatic steatosis after islet transplantation and its relation to graft function
Bhargava, R
Senior, PA
Ackerman, TE
Ryan, EA
Paty, BW
Lakey, JRT
Shapiro, AMJ
[J]. DIABETES, 2004, 53 (05) : 1311 - 1317
[7] CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
Brown, J. Mark
Betters, Jenna L.
Lord, Caleb
Ma, Yinyan
Han, Xianlin
Yang, Kui
Alger, Heather M.
Melchior, John
Sawyer, Janet
Shah, Ramesh
Wilson, Martha D.
Liu, Xiuli
Graham, Mark J.
Lee, Richard
Crooke, Rosanne
Shulman, Gerald I.
Xue, Bingzhong
Shi, Hang
Yu, Liqing
[J]. JOURNAL OF LIPID RESEARCH, 2010, 51 (11) : 3306 - 3315
[8] Selective versus total insulin resistance: A pathogenic paradox
Brown, Michael S.
Goldstein, Joseph L.
[J]. CELL METABOLISM, 2008, 7 (02) : 95 - 96
[9] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
Browning, JD
Szczepaniak, LS
Dobbins, R
Nuremberg, P
Horton, JD
Cohen, JC
Grundy, SM
Hobbs, HH
[J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
[10] New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
Chakravarthy, MV
Pan, ZJ
Zhu, YM
Tordjman, K
Schneider, JG
Coleman, T
Turk, J
Semenkovich, CF
[J]. CELL METABOLISM, 2005, 1 (05) : 309 - 322

← 1 2 3 4 5 6 →